SUO Annual Meeting

In this video interview with Urology Times, Arjun V. Balar, MD, PhD, discusses the current role of PD-1 inhibitors, their mechanism of action, and his own impression of recently presented phase II study data.

“Urologists can play an active role in reducing the opioid epidemic just by prescribing fewer opioids,” says Kathryn Hacker Gessner, MD, PhD, in this video.

In this video, Todd M. Morgan, MD, talks about the still-uncertain future of imaging in advanced prostate cancer.

In a video interview with Urology Times, Robert C. Flanigan, MD, points out the shortcomings of the CARMENA trial, patient selection for cytoreduction, and the future of cytoreductive nephrectomy in the age of PD-1 inhibitors.

In this video, Inderbir S. Gill, MD, discusses data comparing multiple parameters, including intraoperative, perioperative, oncologic, and functional outcomes of open versus robotic surgery

"Urologists in practice now need to have at least some working knowledge in this area because I’ve seen it several times in my academic practice," says one urologist.

Compared with other treatment approaches, definitive surgical extirpation provides the best survival outcomes in patients with invasive, non-urachal adenocarcinoma of the bladder, results of a recent study suggest.